Teleflex Incorporated $TFX Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lowered its position in shares of Teleflex Incorporated (NYSE:TFX) by 8.4% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 202,524 shares of the medical technology company’s stock after selling 18,559 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Teleflex were worth $24,224,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Hsbc Holdings PLC boosted its holdings in shares of Teleflex by 4.7% in the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after acquiring an additional 84 shares in the last quarter. Banque Cantonale Vaudoise raised its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares in the last quarter. Hantz Financial Services Inc. raised its holdings in Teleflex by 40.5% during the fourth quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 113 shares in the last quarter. UMB Bank n.a. lifted its position in Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 113 shares during the period. Finally, Maryland State Retirement & Pension System lifted its position in Teleflex by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after purchasing an additional 129 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on TFX shares. Mizuho boosted their target price on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. UBS Group started coverage on Teleflex in a report on Tuesday. They set a “neutral” rating and a $145.00 price objective on the stock. BMO Capital Markets started coverage on Teleflex in a report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 target price for the company. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. Finally, Wells Fargo & Company increased their price target on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Teleflex has an average rating of “Hold” and an average target price of $148.90.

Teleflex Trading Up 3.3%

Shares of TFX stock opened at $136.72 on Friday. The stock has a market cap of $6.05 billion, a P/E ratio of -6.00, a P/E/G ratio of 1.02 and a beta of 0.82. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67. The business has a fifty day simple moving average of $130.96 and a 200-day simple moving average of $121.37.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. The business had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio is currently -5.96%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.